Liver Diseases  >>  Nplate (romiplostim)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nplate (romiplostim) / Amgen, Kyowa Kirin
NCT01153919: Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia

Terminated
2
27
US
romiplostim, AMG 531, Amgen megakaryopoiesis protein 2, Nplate, ribavirin, ICN-1229, Rebetol, RIBA, RTCA, Viramide, Virazole, placebo, PLCB, PEG-interferon alfa-2a, PEG-IFNA2a, PEGASYS, pegylated interferon alfa-2a, laboratory biomarker analysis
University of Southern California
Hepatitis C Infection, Thrombocytopenia
07/14
07/18

Download Options